Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

OBJECTIVE: To assess safety and efficacy of deflazacort (DFZ) and prednisone (PRED) vs placebo in Duchenne muscular dystrophy (DMD). METHODS: This phase III, double-blind, randomized, placebo-controlled, multicenter study evaluated muscle strength among 196 boys aged 5–15 years with DMD during a 52-...

Descripción completa

Detalles Bibliográficos
Autores principales: Griggs, Robert C., Miller, J. Phillip, Greenberg, Cheryl R., Fehlings, Darcy L., Pestronk, Alan, Mendell, Jerry R., Moxley, Richard T., King, Wendy, Kissel, John T., Cwik, Valerie, Vanasse, Michel, Florence, Julaine M., Pandya, Shree, Dubow, Jordan S., Meyer, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109941/
https://www.ncbi.nlm.nih.gov/pubmed/27566742
http://dx.doi.org/10.1212/WNL.0000000000003217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109941/
https://www.ncbi.nlm.nih.gov/pubmed/27566742
http://dx.doi.org/10.1212/WNL.0000000000003217

Ejemplares similares